Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Cost of Revenue (2020 - 2025)

iSpecimen (ISPC) has 6 years of Cost of Revenue data on record, last reported at $204593.0 in Q3 2025.

  • For Q3 2025, Cost of Revenue fell 87.6% year-over-year to $204593.0; the TTM value through Sep 2025 reached $2.2 million, down 49.41%, while the annual FY2024 figure was $4.9 million, 25.01% up from the prior year.
  • Cost of Revenue reached $204593.0 in Q3 2025 per ISPC's latest filing, down from $658539.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.6 million in Q3 2024 and bottomed at -$108947.0 in Q4 2021.
  • Average Cost of Revenue over 5 years is $823855.3, with a median of $832625.0 recorded in 2022.
  • Peak YoY movement for Cost of Revenue: tumbled 235.43% in 2021, then skyrocketed 939.61% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at -$108947.0 in 2021, then surged by 939.61% to $914725.0 in 2022, then tumbled by 38.46% to $562895.0 in 2023, then skyrocketed by 71.74% to $966712.0 in 2024, then tumbled by 78.84% to $204593.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $204593.0 in Q3 2025, $658539.0 in Q2 2025, and $347140.0 in Q1 2025.